Neurogene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Neurogene Inc. (NGNE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 520 shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2019-03-07
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2018-12-31 was 0.00 shares.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-12-31 was 0.00 shares.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2016-09-30 was 0.00 shares.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2015-12-31 was 0.00 shares.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 520.00 shares.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2016 was 8.01K shares, a 34.20% decline from fiscal 2015.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2015 was 12.17K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 520.00 shares 10-K · filed 2019-03-07 | ||
| 2018-09-30 | 520.00 shares 10-Q · filed 2018-11-07 | |||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-09 | 8.01K shares 10-K · filed 2017-03-09 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 8.01K shares 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | 8.01K shares 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -272.00 shares derived: sum of 2 quarters · filed 2016-03-14 | 728.00 shares derived: sum of 3 quarters · filed 2016-03-14 | 12.17K shares 10-K · filed 2016-03-14 |
| 2015-09-30 | -272.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 728.00 shares derived: sum of 2 quarters · filed 2015-11-10 | 12.17K shares 10-Q · filed 2015-11-10 | |
| 2015-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 12.44K shares 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | 11.44K shares 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |